DAWN

Day One Biopharmaceuticals (DAWN)

About Day One Biopharmaceuticals (DAWN)

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.

Details

Daily high

$14.37

Daily low

$14.12

Price at open

$14.32

52 Week High

$18.07

52 Week Low

$9.67

Market cap

1.3B

Dividend yield

0.00%

Volume

7,064

Avg. volume

1.0M

P/E ratio

-7.40

Day One Biopharmaceuticals News